Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS applied materials & interfaces"
DOI: 10.1021/acsami.5c03559
Abstract: Immune checkpoint blockade (ICB) therapy is an emerging strategy for renal cell carcinoma (RCC). However, its clinical efficacy remains constrained by its inherently poor immunogenicity and insufficient cytotoxic T lymphocyte (CTL) infiltration. Herein, we engineer…
read more here.
Keywords:
copper nanozyme;
biomimetic copper;
cuproptosis;
tumor ... See more keywords